FDA Inspection 1019103 — Community Blood Center
The FDA completed an inspection of Community Blood Center on July 11, 2017 in Fort Worth, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 11, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Fort Worth, TX (United States)